Search icon
TCS, HDFCBANK, SBI Liquid Fund (G)
Ambey Laboratories Ltd.

AMBEY

Equity

NSE

Min. Investment

65,000.00

Open a free Demat account and invest in IPOs easily.

Download Orca

Google PlayApp Store

To access realtime data for GP Eco Solutions India Ltd. and use advance features for Applying IPO. Register or Login to Orca.

IPO Details

Bidding Dates

04 Jul 24 - 08 Jul 24

Price Range ₹

65 - 68

Total Equity

44.68Cr

Lot Size

2000

Exchange Status

NSE

IPO Doc

Subscription Rate

Non-Institutional Investor

0.00×

Qualified Institutional Buyers

0.00×

Employees

0.00×

Retail Investors

0.00×

Total subscription Rate

0.00×

IPO Timeline

Offer start

04 Jul 2024

Offer end

08 Jul 2024

Allotment

09 Jul 2024

Refund initiation

10 Jul 2024

Demat transfer

10 Jul 2024

Listing

11 Jul 2024

About Company

Ambey Laboratories, established in 1985, specializes in manufacturing agrochemical products for crop protection. With nearly four decades of experience in the agrochemical sector, the company produces and supplies 2,4-D base chemicals. The manufacturing facility, located in Behror, Rajasthan, holds ISO 9001:2015 certification from the Quality Research Organization and ISO 14001:2015 certification from the United Accreditation Foundation. Ambey Laboratories' product lineup includes the following: - 2,4-D Acid 98% TC - 2,4-D Sodium 95% SP - 2,4-D Amine 866 | 720 | 480g/l SL - 2,4-D Ethyl Hexyl Ester 96% TC - 2,4-D Ethyl Ester 96% TC - Chlorpyriphos 97%TC / 20%EC / 50%EC - Thiamethoxam 96%TC / 25%WG / 75%SG - Pretilachlor 95%TC / 50%EC / 37%EW - Metribuzin 97%TC / 70%WS - Hexaconazole 92%TC / 5%SC / 5%EC / 10%EC - Metalaxyl 98%TC / 35%WS The company serves a diverse customer base, including major corporations such as Aromatic Rasayan Private Limited, JR Jindal Infraprojects Private Limited, and SC Formulator Co. Ltd. As of October 31, 2023, Ambey Laboratories employs 220 people across various departments.

Year Founded

20-03-1985

Promotor Details

Promoter Holdings Details

ParticularPre-IPOPost-IPO
Percentage94.9769.9
Share Capital1774942017437420

Offer to Public

65,70,000.00 Cr

Project Details

  • To meet out the Working Capital requirements - 309.32cr

Objectives

  • To meet out the Working Capital requirements of the Company
  • To meet out the General Corporate Purposes
  • andTo meet out the Issue Expenses.

Highlights

  • The company boasts an experienced and skilled management team.
  • Ambey Laboratories adheres to stringent quality assurance and standards.
  • The company maintains cordial and strong relationships with its suppliers.
  • Focused on improving financial performance through enhanced operational and functional efficiencies.
  • The company is dedicated to backward integration for raw material manufacturing, forward integration of finished goods, increasing installed capacity, leveraging market skills and leadership in 2,4-D, and expanding the customer base while increasing wallet share with existing customers.

Challenges

  • Several key properties, including the company's registered office, are not owned by Ambey Laboratories. Failure to renew or termination of lease/rent agreements could disrupt company operations.
  • The Rajasthan State Pollution Control Board has directed the company to pay Rs.1,92,02,400 as environmental compensation, indicating potential regulatory challenges and financial liabilities.
  • The use of hazardous, corrosive, and flammable materials in production poses risks. Accidents could result in loss of life, property damage, and operational disruptions, adversely affecting financial results and cash flows.
  • A significant portion of the company's revenue is dependent on a few major clients. Losing any of these clients would materially impact business operations and profitability.
  • The company requires numerous approvals, licenses, registrations, and permits to operate. Failure to obtain or renew these in a timely manner, or operating without necessary permissions, could lead to civil and criminal sanctions, adversely affecting operations.

Financials

YearsTotal AssetsShare CapitalProfit After TaxConsolidated Net ProfitAdjusted EPS
20213,739.22489.351,033.671,033.6721.1233
20224,995.941,774.941,033.671,033.6721.1233
20235,359.111,774.941,033.671,033.6721.1233
20247,673.531,868.881,033.671,033.6721.1233
Enrich money logo